This webinar we explore important considerations for developing a Direct-to-Patient strategy and the RTSM features needed to support its execution.
Topics to be discussed include:
- The impact of COVID-19 on clinical trials, including perspectives from patients, sites and sponsors
- Whether or not DtP makes sense for you trial, and if so, what model?
- The RTSM as a solution when implementing a robust DtP strategy
- Key considerations for a DtP strategy, including an actionable checklist to discuss with your team